Email address
[email protected]Contact number
+1 416 865 8145Share profile
Provided by John Emanoilidis
Advising on mergers and acquisitions, corporate finance transactions and other significant corporate matters across industries, John is co-head of the firm’s M&A Practice and is widely recognized as one of Canada’s leading corporate and securities lawyers, with deep deal acumen and strong technical skill to advance clients’ business strategies.
John has a broad range of experience in complex M&A, transactional, securities, private equity, regulatory, governance, activism and compliance matters. With an international range of clients, John represents domestic and foreign acquirors, private equity sponsors, targets, special committees, boards of directors and investment banks in all aspects of M&A (both public and private), including hostile takeover bids, strategic review processes, proxy contests, going-private transactions, private equity transactions and negotiated acquisitions.
John regularly advises companies, directors and shareholders on corporate governance, crisis management, activism, compliance and other critical situations.
John also has extensive experience in corporate finance transactions, representing issuers, underwriters and investors in domestic and international debt and equity public offerings and private placements.
Provided by Chambers
Provided by Chambers
John is one of the most sophisticated M&A lawyers. He did some excellent work and I would highly recommend him to anyone.
John was a highly additive member of our team and provided superb advice and service.
John provides outstanding counsel on complex governance and M&A transactions.
John is one of the most sophisticated M&A lawyers. He did some excellent work and I would highly recommend him to anyone.
John was a highly additive member of our team and provided superb advice and service.
John provides outstanding counsel on complex governance and M&A transactions.
7 items provided by Torys LLP
Key priorities for boards in 2022
The role of directors is more interesting and challenging than ever—the dynamic nature of the pandemic and shifting global markets mean continued uncertainty and persistent evolution in the way corporations do business. Below are six priorities for directors as they navigate this disruptive time.
On its face, record-breaking M&A levels in Canada in 2021 appear to be setting the stage for an eventful year in deal-making in 2022. However, deal activity is only part of the story of 2021 for dealmakers in Canada. M&A this year will be shaped by a diverse range of drivers.
As the COVID-19 vaccination program rolls out nationwide, corporate Canada’s decision-makers are putting domestic and cross-border growth plans to work. This article examines domestic and international merger trends and opportunities within a changed post-pandemic business environment.
Although many businesses put their M&A plans on hold at the beginning of COVID-19, deal activity significantly rebounded in the second half of the year. Parties successfully overcame numerous unprecedented challenges. This article surveys Canadian M&A activity in 2020 and previews the upcoming year.
Torys Quarterly: Financial advisors and contested transactions
With heightened M&A activity in financial services, industry practices are evolving to address conflicts of interest for the investment banks involved. Here, we survey where financial advisors can be attacked within a contested transaction and practices designed to mitigate such risks.
Torys Quarterly: Will a “Canada First” sentiment curb M&A?
As fallout from the crisis continues to unfold, concerns about globalization are paramount. Factors crucial to business, such as public sentiment, regulations and the political climate are in flux. In this article, we examine Canada’s M&A market and attitudes to foreign investment and transactions.
Torys Quarterly: Redefining M&A strategy for the post-pandemic world
Business leaders across the globe have focused foremost on continuity concerns amid the COVID-19 crisis.
Key priorities for boards in 2022
The role of directors is more interesting and challenging than ever—the dynamic nature of the pandemic and shifting global markets mean continued uncertainty and persistent evolution in the way corporations do business. Below are six priorities for directors as they navigate this disruptive time.
On its face, record-breaking M&A levels in Canada in 2021 appear to be setting the stage for an eventful year in deal-making in 2022. However, deal activity is only part of the story of 2021 for dealmakers in Canada. M&A this year will be shaped by a diverse range of drivers.
As the COVID-19 vaccination program rolls out nationwide, corporate Canada’s decision-makers are putting domestic and cross-border growth plans to work. This article examines domestic and international merger trends and opportunities within a changed post-pandemic business environment.
Although many businesses put their M&A plans on hold at the beginning of COVID-19, deal activity significantly rebounded in the second half of the year. Parties successfully overcame numerous unprecedented challenges. This article surveys Canadian M&A activity in 2020 and previews the upcoming year.
Torys Quarterly: Financial advisors and contested transactions
With heightened M&A activity in financial services, industry practices are evolving to address conflicts of interest for the investment banks involved. Here, we survey where financial advisors can be attacked within a contested transaction and practices designed to mitigate such risks.
Torys Quarterly: Will a “Canada First” sentiment curb M&A?
As fallout from the crisis continues to unfold, concerns about globalization are paramount. Factors crucial to business, such as public sentiment, regulations and the political climate are in flux. In this article, we examine Canada’s M&A market and attitudes to foreign investment and transactions.
Torys Quarterly: Redefining M&A strategy for the post-pandemic world
Business leaders across the globe have focused foremost on continuity concerns amid the COVID-19 crisis.